Search Results
Oct 13, 2025, 12:53 ET Nuvalent to Present New Preclinical Data for HER2-Selective Inhibitor, NVL-330, at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
brain metastases, and drive more durable responses. Nuvalent is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer, and multiple discovery-stage research programs.
More news about: Nuvalent, Inc.
Oct 06, 2025, 13:25 ET Alaska Air Group announces webcast of third-quarter 2025 financial results
Hawaiian. Alaska Air Group is traded on the New York Stock Exchange (NYSE) as "ALK."
More news about: Alaska Air Group
Sep 29, 2025, 06:30 ET Diagonal Therapeutics to Present New Preclinical Data Demonstrating Disease-Modifying Potential of DIAG723 in Pulmonary Arterial Hypertension at 2025 ERS Congress
pressure, right ventricle hypertrophy, heart failure and eventually death. Defective ALK1 signaling has been implicated in the onset and progression of PAH. DIAG723 is a first-in-class bispecific antibody designed to cluster ALK1 and BMPRII receptors to stimulate antiproliferative signaling, preventing the
More news about: Diagonal Therapeutics
Sep 26, 2025, 13:15 ET Alaska Air Group Announces Leadership Transitions at Alaska Airlines and Horizon Air
news.alaskaair.com. Alaska Air Group is traded on the New York Stock Exchange (NYSE) as "ALK."
More news about: Alaska Airlines
Sep 24, 2025, 09:00 ET Introducing Atmos™ for Business - an innovative ecosystem for business travel that rewards companies and their employees
news.alaskaair.com. Alaska Air Group is traded on the New York Stock Exchange (NYSE) as "ALK."
More news about: Alaska Airlines
Sep 24, 2025, 06:30 ET Nuvalent to Participate in the UBS 2025 Virtual Oncology Day
brain metastases, and drive more durable responses. Nuvalent is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer, and multiple discovery-stage research programs.
More news about: Nuvalent, Inc.
Sep 22, 2025, 09:00 ET Galux Demonstrates De Novo Antibody Design With Structural and Functional Validation Across Eight Targets
study extends this work to two additional targets, CD98hc and IL-11, bringing the total to eight: PD-L1, HER2, EGFR(S468R mutant), ACVR2A/B, FZD7, ALK7, CD98hc, and IL-11. Notably, IL-11 represents a target without any known antibody complex structure, highlighting the platform's capacity to tackle previously
More news about: Galux
Sep 22, 2025, 08:00 ET Alaska Airlines unveils bold Lounge expansion plans in San Diego
news.alaskaair.com. Alaska Air Group is traded on the New York Stock Exchange (NYSE) as "ALK."
More news about: Alaska Airlines
Sep 16, 2025, 10:06 ET Promising New Preclinical Therapy Offers Hope in the Development of Precision Medicine Treatments for Aggressive Cancers
expressing ALK, and likely also to neighboring tumor cells which may not necessarily express ALK, a phenomenon referred to as the "bystander effect." Moving forward, the research team is working on refining the technology to meet strict regulatory requirements for developing a first-in-class ALK-directed
More news about: Children's Hospital of Philadelphia
Sep 15, 2025, 10:45 ET Immunohistochemistry Market worth US$5.14 billion by 2030 with 7.6% CAGR | MarketsandMarkets™
for market leadership involves consistent innovation, exemplified by recent launches such as the BenchMark ULTRA PLUS system (2022) and the VENTANA ALK (D5F3) CDx Assay (2021). Its robust product pipeline and recent approvals for new antibodies and systems underscore its significant global footprint
More news about: MarketsandMarkets
Sep 10, 2025, 17:00 ET Alaska Air Group Announces Leadership Transition at Hawaiian Airlines and Executive Promotion at Alaska Airlines
news.alaskaair.com. Alaska Air Group is traded on the New York Stock Exchange (NYSE) as "ALK."
More news about: Alaska Airlines
Sep 10, 2025, 08:00 ET Set your sights on Seoul! Alaska Airlines launches new nonstop service from Seattle with limited-time BOGO deal and redemptions starting at 20,000 points
news.alaskaair.com. Alaska Air Group is traded on the New York Stock Exchange (NYSE) as "ALK."
More news about: Alaska Airlines